References |
Top |
REF 1 |
Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol Cell Biol. 2002 Sep;22(18):6471-9.
|
REF 2 |
Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol Cancer. 2010 Oct 22;9:280.
|
REF 3 |
Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 2000 Oct 1;14(19):2441-51.
|
REF 4 |
Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site. Glia. 2009 Jul;57(9):989-99.
|
REF 5 |
The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by -Arrestin1 binding with P300-Sp1 to regulate hTERT transcription. Cell Death Dis. 2017 Apr 20;8(4):e2756.
|
REF 6 |
Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol. 2006 Mar;26(5):1770-85.
|
REF 7 |
Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology. 2001 Sep;142(9):3817-27.
|
REF 8 |
ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J Biol Chem. 2007 Sep 14;282(37):27215-28.
|
REF 9 |
Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration. J Cell Biochem. 2012 Aug;113(8):2597-606.
|
REF 10 |
P300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene. 2008 Mar 20;27(13):1894-904.
|
REF 11 |
Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell. 2000 Sep;6(3):551-61.
|
REF 12 |
Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter. J Biol Chem. 2003 Sep 19;278(38):36496-504.
|
REF 13 |
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cyc... J Biol Chem. 2005 Feb 4;280(5):3185-96.
|
REF 14 |
The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J Biol Chem. 2002 Sep 27;277(39):35783-6.
|
REF 15 |
Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem Biophys Res Commun. 2002 Aug 30;296(4):1005-12.
|
REF 16 |
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem Cell Biol. 2007 Dec;85(6):751-8.
|
REF 17 |
Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. J Biol Chem. 2002 Sep 6;277(36):33431-8.
|
REF 18 |
Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 2002 Mar 14;21(12):1812-22.
|
REF 19 |
HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene. 2009 Jan 15;28(2):243-56.
|
REF 20 |
Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. Cell Physiol Biochem. 2005;16(1-3):23-30.
|
REF 21 |
Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem. 2005 Apr 22;280(16):16467-75.
|
REF 22 |
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol. 2005 Mar;25(5):1608-19.
|
REF 23 |
The repressor element silencing transcription factor (REST)-mediated transcriptional repression requires the inhibition of Sp1. J Biol Chem. 2005 Jan 7;280(1):401-7.
|
REF 24 |
Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem. 2004 Jul 30;279(31):32620-5.
|
REF 25 |
The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells. J Leukoc Biol. 2008 Jan;83(1):190-9.
|
REF 26 |
Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy. Leukemia. 2010 Mar;24(3):552-62.
|
REF 27 |
Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. J Biol Chem. 2011 Jul 22;286(29):25813-22.
|
REF 28 |
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol. 2003 Apr;23(8):2669-79.
|
REF 29 |
Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol. 2001 Feb 16;306(2):201-12.
|
REF 30 |
Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001 Oct 15;20(20):5737-47.
|
REF 31 |
Hsp90alpha recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells. J Biol Chem. 2005 Oct 28;280(43):36283-92.
|
REF 32 |
Heat shock protein 90 is important for Sp1 stability during mitosis. J Mol Biol. 2009 Apr 17;387(5):1106-19.
|
REF 33 |
Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene. 2012 Nov 22;31(47):4946-59.
|
REF 34 |
Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis. Nucleic Acids Res. 2014 Dec 16;42(22):13573-87.
|
REF 35 |
Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer J Biochem. 2012 Jun;151(6):599-610.
|
REF 36 |
Interplay between PKC and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. J Virol. 2011 Mar;85(5):2373-85.
|
REF 37 |
Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta. Oncogene. 2009 Mar 19;28(11):1410-20.
|
REF 38 |
Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Mol Cell Biol. 2006 Sep;26(18):6748-61.
|
REF 39 |
Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1. Circ Res. 2008 Feb 29;102(4):e38-51.
|
REF 40 |
A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor. J Biol Chem. 2006 Jul 7;281(27):18825-36.
|
REF 41 |
17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. J Immunol. 2007 Mar 1;178(5):3059-66.
|
REF 42 |
Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes. Endocrinology. 2007 Oct;148(10):4821-8.
|
REF 43 |
Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2. J Biol Chem. 2009 Oct 16;284(42):28607-15.
|
REF 44 |
Differential intranuclear organization of transcription factors Sp1 and Sp3. Mol Biol Cell. 2005 Sep;16(9):4073-83.
|
REF 45 |
Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol. 2006 May;20(5):1035-47.
|
REF 46 |
Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. J Steroid Biochem Mol Biol. 2004 Feb;88(2):113-22.
|
REF 47 |
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem. 2000 Feb 25;275(8):5379-87.
|
REF 48 |
Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells. Circ Res. 2005 Mar 18;96(5):518-25.
|
REF 49 |
Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J Clin Endocrinol Metab. 2008 May;93(5):1915-23.
|
REF 50 |
Retinoic acid activates monoamine oxidase B promoter in human neuronal cells. J Biol Chem. 2009 Jun 19;284(25):16723-35.
|
REF 51 |
Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One. 2010 Mar 29;5(3):e9912.
|
REF 52 |
The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. Endocr Relat Cancer. 2008 Mar;15(1):325-35.
|
REF 53 |
Transcriptional regulation of human eosinophil RNase2 by the liver-enriched hepatocyte nuclear factor 4. J Cell Biochem. 2009 Feb 1;106(2):317-26.
|
REF 54 |
Negative autoregulation of HNF-4alpha gene expression by HNF-4alpha1. Biochem J. 2005 May 15;388(Pt 1):325-32.
|
REF 55 |
Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene. 2005 Mar 3;24(10):1738-48.
|
REF 56 |
Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem. 1998 Aug 7;273(32):20052-7.
|
REF 57 |
p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett. 2005 Feb 14;579(5):1001-7.
|
REF 58 |
p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology. 1998 Mar;139(3):1101-7.
|
REF 59 |
DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell. 2004 Dec 3;16(5):725-36.
|
REF 60 |
p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. Anticancer Res. 2009 Oct;29(10):3741-50.
|
REF 61 |
Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner Res. 2006 May;21(5):661-73.
|
REF 62 |
The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. PLoS Genet. 2013 Jun;9(6):e1003557.
|
REF 63 |
Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. J Biol Chem. 2000 Aug 11;275(32):24583-9.
|
REF 64 |
ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J Biol Chem. 2003 Jan 10;278(2):875-84.
|
REF 65 |
Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells. Oncogene. 2004 Sep 9;23(41):6942-53.
|
REF 66 |
Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002 Nov 15;277(46):43799-808.
|
REF 67 |
Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation. J Biol Chem. 2001 Sep 14;276(37):34486-94.
|
REF 68 |
Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000 Sep 22;275(38):29244-56.
|
REF 69 |
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells. Biochim Biophys Acta. 2012 Feb;1823(2):570-81.
|
REF 70 |
The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. EMBO J. 2006 Oct 18;25(20):4784-94.
|
REF 71 |
HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell. 2005 Mar 18;17(6):793-803.
|
REF 72 |
O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. FEBS Lett. 2009 Feb 4;583(3):512-20.
|
REF 73 |
The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. Nucleic Acids Res. 1996 Jun 1;24(11):1981-6.
|
REF 74 |
A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. Mol Cell Biochem. 2000 Jul;210(1-2):131-42.
|
REF 75 |
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4510-5.
|
REF 76 |
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007 Apr;11(4):335-47.
|
REF 77 |
NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. Am J Physiol Cell Physiol. 2002 Jul;283(1):C58-65.
|
REF 78 |
Endothelin-1 induces glut1 transcription through enhanced interaction between Sp1 and NF-kappaB transcription factors. Cell Signal. 2008 Apr;20(4):771-8.
|
REF 79 |
NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression. J Immunol. 2010 Oct 15;185(8):4896-903.
|
REF 80 |
Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J Virol. 1994 Nov;68(11):7131-8.
|
REF 81 |
Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene. 1999 Jun 24;234(1):61-9.
|
REF 82 |
Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol. 1999 Aug;13(8):1373-87.
|
REF 83 |
TGF-1 downregulates AT1 receptor expression via PKC--mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR- association with KLF4. Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1015-23.
|
REF 84 |
The gut-enriched Krpel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem. 1998 Jul 10;273(28):17917-25.
|
REF 85 |
PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells. Mol Biol Cell. 2007 Mar;18(3):1118-27.
|
REF 86 |
c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem. 1999 Oct 8;274(41):29572-81.
|
REF 87 |
MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. J Biol Chem. 2009 Feb 20;284(8):5165-74.
|
REF 88 |
Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 2005 Nov 28;33(20):6528-39.
|
REF 89 |
Growth-dependent repression of human adenine nucleotide translocator-2 (ANT2) transcription: evidence for the participation of Smad and Sp family proteins in the NF1-dependent repressor complex. Biochem J. 2008 May 15;412(1):123-30.
|
REF 90 |
Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers. Oncotarget. 2014 Oct 15;5(19):9349-61.
|
REF 91 |
Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol. 1996 Apr;16(4):1668-75.
|
REF 92 |
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol. 2003 Apr;23(8):2720-32.
|
REF 93 |
Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 1999 Apr 29;398(6730):828-32.
|
REF 94 |
Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein. J Biol Chem. 1999 May 7;274(19):13025-32.
|
REF 95 |
Modulation of IFN- receptor 1 expression by AP-2 influences IFN- sensitivity of cancer cells. Am J Pathol. 2012 Feb;180(2):661-71.
|
REF 96 |
Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene. 2007 Jun 28;26(30):4394-403.
|
REF 97 |
Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. BMC Cancer. 2014 Nov 3;14:796.
|
REF 98 |
GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression. Neoplasia. 2010 Nov;12(11):856-65.
|
REF 99 |
GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. Mol Endocrinol. 2004 May;18(5):1144-57.
|
REF 100 |
A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell. 1998 Dec;2(6):751-9.
|
REF 101 |
Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners. FEBS Lett. 2003 May 22;543(1-3):61-5.
|
REF 102 |
Regulation of Transcription Factor SP1 by the -Catenin Destruction Complex Modulates Wnt Response. Mol Cell Biol. 2018 Oct 29;38(22). pii: e00188-18.
|